Whether ahead of their time, truly bizarre, or just plain doomed, it’s certainly interesting to see companies go completely ...
Nearly 12 months later, green shoots may finally be appearing following a desperately dark time for the German group that invented aspirin. Bayer announced plans earlier this year to secure €2 ...
A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...
Bayer is pressing ahead with a phase 3 trial ... stroke or stent thrombosis compared to placebo – both given alongside aspirin plus a P2Y12 inhibitor – at one year. Once again, there was ...
These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...